Evidence map›Paper›PMID 33692195›Full record

ArticlemSphere2021

Comparative Study of the Susceptibility to Oxidative Stress between Two Types of Mycobacterium bovis BCG Tokyo 172.

Keiichi Taniguchi, Daisuke Hayashi, Naomi Yasuda, Mao Nakayama, Kaori Yazawa, Shouta Ogawa, Yuji Miyatake, Saki Suda, Haruka Tomita, Miki Tokuda and 7 more

Open access · goldAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Keiichi TaniguchiDepartment of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan.
Daisuke HayashiJapan BCG Laboratory, Kiyose, Tokyo, Japan.
Naomi YasudaDepartment of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Tokyo, Japan.
Mao NakayamaDepartment of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Tokyo, Japan.
Kaori YazawaDepartment of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Tokyo, Japan.
Shouta OgawaDepartment of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan.
Yuji MiyatakeDepartment of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan.
Saki SudaDepartment of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan.
Haruka TomitaDepartment of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan.
Miki TokudaDepartment of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan.
Saotomo ItohDepartment of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan.
Jun-Ichi MaeyamaDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Naoya OharaDepartment of Oral Microbiology, Graduated School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Saburo YamamotoJapan BCG Laboratory, Kiyose, Tokyo, Japan.
Shigeaki HidaDepartment of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan.
Kikuo OnozakiDepartment of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan.
Takemasa TakiiDepartment of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan t-takii@jata.or.jp.ORCID 0000-0002-5005-0941
Nagoya City University · JPJapan Anti Tuberculosis Association · JPJapan BCG Laboratory · JPNational Institute of Infectious Diseases · JPOkayama University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genomic analysis revealed that the vaccine seed lot of

Indexed as

AnimalsBCG VaccineCytokinesGenome, BacterialHumansHydrogen PeroxideMacrophagesMiceMycobacterium bovisMycobacterium tuberculosisOxidative StressRAW 264.7 CellsTHP-1 CellsTokyoTuberculosisBCG VaccineCytokinesHydrogen PeroxideBCG vaccinecytokineMycobacterium tuberculosisNADPH oxidaseredox

Identifiers

PMID33692195
PMCPMC8546687
OpenAlexW3134119622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.